Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03451240 · ClinicalTrials.gov registry record · NA
A Mixed Methods Evaluation of HPI Resilience Intervention Study
A NA study of Stress, sponsored by Johnson & Johnson Health and Wellness Solutions.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03451240: Completed NA study of Stress, sponsored by Johnson & Johnson Health and Wellness Solutions.
NCT03451240 is a NA study of Stress that has completed, run by Johnson & Johnson Health and Wellness Solutions. The registered enrollment target is 30 participants, below the 786-participant average among 152 other Stress trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03451240, a NA study of Stress, has completed, sponsored by Johnson & Johnson Health and Wellness Solutions.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of the Resilience Study is to determine the impact of the Corporate Athlete® Resilience product through recalibrating mindset and changing resilience supportive behavior. Analysis will be performed via Survey and Study Interviews (two methods) to determine how the CAR Training recalibrated and impacted the Research Participants mindset and resilience state. 1\. Tool: Stress Mindset Measure-General (SMM-G) Additional analysis will evaluate participants' engagement in behavior changes in the first 30 days. 2\. Tool: Energy Management Behaviors. Secondary objectives include further analysis to determine if the intervention group demonstrated significant improvements in the following measures: 1\. Brief Resilience Scale (BRS) 2\. Public Health Surveillance Wellbeing (PHS-WB) 3\. Sleep Habits (Rand MOS) 4\. Health, Wellbeing and Productivity (SF36, HPQ) 5\. Work Productivity and Activity Impairment (WPAI) 6\. Brief Cope 7\. Perceived Stress (PSS) In addition, demographic assessments will be collected.
Primary Outcome
The Stress Mindset Measure-General (SMM-G) is an 8-item measure developed to address the extent to which an individual adopts a mindset that the effects of stress are enhancing or debilitating.
Conditions Studied
Interventions
- BEHAVIORAL Corporate Athlete® Resilience
Study Locations (1)
Florida
- The Human Performance Institute - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-09-16 |
| Est. Completion | 2017-12-31 |
| Phase | NA |
What the finished NCT03451240 record still lists
NCT03451240 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 786-participant average among 152 other Stress trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Stress appearing as the primary indexed condition, and to 1 intervention - of which Corporate Athlete® Resilience is the first listed.
NCT03451240 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03451240 about?
NCT03451240 is a clinical study titled "A Mixed Methods Evaluation of HPI Resilience Intervention Study". The primary objective of the Resilience Study is to determine the impact of the Corporate Athlete® Resilience product through recalibrating mindset and changing resilience supportive behavior. Analysis will be performed via Survey and Study Interviews (two methods) to determine how the CAR Training...
What is the current status of trial NCT03451240?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-09-16. Estimated completion is 2017-12-31.
What conditions does trial NCT03451240 study?
This clinical trial studies the following conditions: Stress.
What interventions are being tested in trial NCT03451240?
The interventions under investigation include: Corporate Athlete® Resilience (BEHAVIORAL).
Who is sponsoring clinical trial NCT03451240?
This trial is sponsored by Johnson & Johnson Health and Wellness Solutions, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03451240 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03451240's enrollment target sits among peer trials
30 132nd of 152 higher than 16 of 152 other Stress trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness-Based Intervention With a Supplement for Stress-Related Problems in College Students Across Multiple Sites (4SITE)
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
ACT for HIV-Positive Men
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI